Trial Profile
A Study to Evaluate the Pharmacokinetics, Efficacy, Safety and Feasibility of Posaconazole Oral Antifungal Prophylaxis in Pediatric and Adolescent Patients after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jan 2016
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Aspergillosis; Candidiasis; Chagas disease; Mycoses
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 27 Jan 2016 New trial record
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology